News: BioSante Pharmaceuticals Inc (BPAX.A)
BPAX.A on American Stock Exchange
1.23USD
2:56pm EDT
1.23USD
2:56pm EDT
Price Change (% chg)
$-0.05 (-3.91%)
$-0.05 (-3.91%)
Prev Close
$1.28
$1.28
Open
$1.24
$1.24
Day's High
$1.25
$1.25
Day's Low
$1.23
$1.23
Volume
600
600
Avg. Vol
1,911
1,911
52-wk High
$2.77
$2.77
52-wk Low
$1.02
$1.02
Select another date:
Select another date:
Press Releases
- BioSante Pharmaceuticals Reports Third Quarter Financial Results and Merger Update
- BioSante Pharmaceuticals, Inc. to Present at BIO Investor Forum
- BioSante Pharmaceuticals Announces Positive LibiGel® Phase III Safety Data Review and Decision to Conclude the Safety Study
- BioSante Pharmaceuticals, Inc. to Present at Stifel Nicolaus Healthcare Conference and Rodman & Renshaw Global Investment Conference
- BioSante Pharmaceuticals Closes $3,475,000 Registered Direct Offering
- BioSante Pharmaceuticals to Raise $3,475,000 in Registered Direct Offering
- BioSante Pharmaceuticals Reports Second Quarter Financial Results and Pipeline Update
- BioSante Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement
- BioSante Pharmaceuticals Announces New LibiGel® Phase III Efficacy Trials
- BioSante Pharmaceuticals, Inc. to Present at Jefferies Global Healthcare Conference
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
